Cargando…

RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes

BACKGROUND: The Ras Association Domain Family Member 1 (RASSF1) is one of the most frequently reported methylation-inactivated tumor suppressor genes in primary pancreatic ductal adenocarcinomas (PDAC). Limited information is still available about the impact of RASSF1 gene silencing on the expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Amato, Eliana, Barbi, Stefano, Fassan, Matteo, Luchini, Claudio, Vicentini, Caterina, Brunelli, Matteo, Malleo, Giuseppe, Scarpa, Aldo, Malpeli, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710004/
https://www.ncbi.nlm.nih.gov/pubmed/26754001
http://dx.doi.org/10.1186/s12885-016-2048-0
_version_ 1782409758600331264
author Amato, Eliana
Barbi, Stefano
Fassan, Matteo
Luchini, Claudio
Vicentini, Caterina
Brunelli, Matteo
Malleo, Giuseppe
Scarpa, Aldo
Malpeli, Giorgio
author_facet Amato, Eliana
Barbi, Stefano
Fassan, Matteo
Luchini, Claudio
Vicentini, Caterina
Brunelli, Matteo
Malleo, Giuseppe
Scarpa, Aldo
Malpeli, Giorgio
author_sort Amato, Eliana
collection PubMed
description BACKGROUND: The Ras Association Domain Family Member 1 (RASSF1) is one of the most frequently reported methylation-inactivated tumor suppressor genes in primary pancreatic ductal adenocarcinomas (PDAC). Limited information is still available about the impact of RASSF1 gene silencing on the expression of its different isoforms in neoplastic cells. METHODS: A series of 96 primary PDAC, with known clinico-pathological parameters, was tested for RASSF1 methylation status by methylation-specific PCR, RASSF1 locus copy number alterations by fluorescence in situ hybridization, and Rassf1a protein expression by immunohistochemistry. A further series of 14 xenografted primary PDAC and 8 PDAC-derived cell lines were tested to obtain a detailed methylation mapping of CpG islands A and C of the RASSF1 locus by pyrosequencing and to evaluate the expression of Rassf1 variants by qRT-PCR. RESULTS: Methylation of CpG island A of the RASSF1 gene was observed in 35 % of the tumors and allelic loss of RASSF1 locus was seen in 30 disomic and in 20 polysomic cases (52 %). Rassf1a immunohistochemical expression was downregulated in half of primary PDAC, and this downregulation was neither correlated with methylation of RASSF1 promoter nor with RASSF1 copy number alterations. RASSF1 status did not influence patients’ prognosis. The expression of the seven RASSF1 isoforms in xenografts and cell lines showed that RASSF1A, RASSF1B, and RASSF1C isoforms were present in all xenografts and cell lines, whereas RASSF1D, RASSF1E, and RASSF1F isoforms were variably expressed among samples. RASSF1G was never expressed in either xenografts or cell lines. The variable expression of RASSF1 isoforms in PDAC xenografts and cell lines was not dependent on RASSF1 methylation status of CpG islands A and C. CONCLUSIONS: RASSF1 alterations occurring in PDAC mainly consist in variations of expression of the different isoforms. Different genetic mechanisms seem to contribute to RASSF1 deregulation in this setting, but RASSF1 methylation does not seem to substantially affect RASSF1 isoforms expression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2048-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4710004
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47100042016-01-13 RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes Amato, Eliana Barbi, Stefano Fassan, Matteo Luchini, Claudio Vicentini, Caterina Brunelli, Matteo Malleo, Giuseppe Scarpa, Aldo Malpeli, Giorgio BMC Cancer Research Article BACKGROUND: The Ras Association Domain Family Member 1 (RASSF1) is one of the most frequently reported methylation-inactivated tumor suppressor genes in primary pancreatic ductal adenocarcinomas (PDAC). Limited information is still available about the impact of RASSF1 gene silencing on the expression of its different isoforms in neoplastic cells. METHODS: A series of 96 primary PDAC, with known clinico-pathological parameters, was tested for RASSF1 methylation status by methylation-specific PCR, RASSF1 locus copy number alterations by fluorescence in situ hybridization, and Rassf1a protein expression by immunohistochemistry. A further series of 14 xenografted primary PDAC and 8 PDAC-derived cell lines were tested to obtain a detailed methylation mapping of CpG islands A and C of the RASSF1 locus by pyrosequencing and to evaluate the expression of Rassf1 variants by qRT-PCR. RESULTS: Methylation of CpG island A of the RASSF1 gene was observed in 35 % of the tumors and allelic loss of RASSF1 locus was seen in 30 disomic and in 20 polysomic cases (52 %). Rassf1a immunohistochemical expression was downregulated in half of primary PDAC, and this downregulation was neither correlated with methylation of RASSF1 promoter nor with RASSF1 copy number alterations. RASSF1 status did not influence patients’ prognosis. The expression of the seven RASSF1 isoforms in xenografts and cell lines showed that RASSF1A, RASSF1B, and RASSF1C isoforms were present in all xenografts and cell lines, whereas RASSF1D, RASSF1E, and RASSF1F isoforms were variably expressed among samples. RASSF1G was never expressed in either xenografts or cell lines. The variable expression of RASSF1 isoforms in PDAC xenografts and cell lines was not dependent on RASSF1 methylation status of CpG islands A and C. CONCLUSIONS: RASSF1 alterations occurring in PDAC mainly consist in variations of expression of the different isoforms. Different genetic mechanisms seem to contribute to RASSF1 deregulation in this setting, but RASSF1 methylation does not seem to substantially affect RASSF1 isoforms expression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2048-0) contains supplementary material, which is available to authorized users. BioMed Central 2016-01-12 /pmc/articles/PMC4710004/ /pubmed/26754001 http://dx.doi.org/10.1186/s12885-016-2048-0 Text en © Amato et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Amato, Eliana
Barbi, Stefano
Fassan, Matteo
Luchini, Claudio
Vicentini, Caterina
Brunelli, Matteo
Malleo, Giuseppe
Scarpa, Aldo
Malpeli, Giorgio
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes
title RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes
title_full RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes
title_fullStr RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes
title_full_unstemmed RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes
title_short RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes
title_sort rassf1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710004/
https://www.ncbi.nlm.nih.gov/pubmed/26754001
http://dx.doi.org/10.1186/s12885-016-2048-0
work_keys_str_mv AT amatoeliana rassf1tumorsuppressorgeneinpancreaticductaladenocarcinomacorrelationofexpressionchromosomalstatusandepigeneticchanges
AT barbistefano rassf1tumorsuppressorgeneinpancreaticductaladenocarcinomacorrelationofexpressionchromosomalstatusandepigeneticchanges
AT fassanmatteo rassf1tumorsuppressorgeneinpancreaticductaladenocarcinomacorrelationofexpressionchromosomalstatusandepigeneticchanges
AT luchiniclaudio rassf1tumorsuppressorgeneinpancreaticductaladenocarcinomacorrelationofexpressionchromosomalstatusandepigeneticchanges
AT vicentinicaterina rassf1tumorsuppressorgeneinpancreaticductaladenocarcinomacorrelationofexpressionchromosomalstatusandepigeneticchanges
AT brunellimatteo rassf1tumorsuppressorgeneinpancreaticductaladenocarcinomacorrelationofexpressionchromosomalstatusandepigeneticchanges
AT malleogiuseppe rassf1tumorsuppressorgeneinpancreaticductaladenocarcinomacorrelationofexpressionchromosomalstatusandepigeneticchanges
AT scarpaaldo rassf1tumorsuppressorgeneinpancreaticductaladenocarcinomacorrelationofexpressionchromosomalstatusandepigeneticchanges
AT malpeligiorgio rassf1tumorsuppressorgeneinpancreaticductaladenocarcinomacorrelationofexpressionchromosomalstatusandepigeneticchanges